PP_1170x120_10-25-21

John Incledon

Hisamitsu America launches Salonpas Arthritis Pain Relief Gel

Hisamitsu America launches Salonpas Arthritis Pain Relief Gel

FLORHAM PARK, N.J.— Hisamitsu America, a division of Hisamitsu Pharmaceutical Co., Inc., and the manufacturers of the Salonpas line of pain-relieving products, announce the availability of the Salonpas Arthritis Pain Relief Gel, which features the most prescribed topical pain medicine clinically proven to relieve arthritis pain in major joints. That medicine is prescription-strength diclofenac, which was approved

The Journal of Pain Research features topical analgesic pain relief study

The Journal of Pain Research features topical analgesic pain relief study

FLORHAM PARK, N.J. — Hisamitsu America, the marketers of Salonpas, announced Monday that The Journal of Pain Research, an international, peer-reviewed scientific journal focusing on pain research and the prevention and management of pain, features the publication, in June 2020, of the RELIEF study: “Relieving Pain: Evaluating Patient Quality of Life Improvement – Perceptions, Experience and

Salonpas celebrates Salonpas Day with product donation to “NYC Healthcare Heroes” program

Salonpas celebrates Salonpas Day with product donation to “NYC Healthcare Heroes” program

FLORHAM PARK, N.J. — Hisamitsu America is once again proud to announce that May 18, 2020 is “Salonpas Day” which signals a day free from pain from the world leader in medicinal pain patches. While this day has been traditionally celebrated by passing out free samples to the public, this year, as the ‘new normal’ has dramatically shifted, the

Hisamitsu America intros new Salonpas Pain Relief Patch Large in value pack

Hisamitsu America intros new Salonpas Pain Relief Patch Large in value pack

FLORHAM PARK, N.J.— Hisamitsu America announce the availability of the Salonpas Pain Relief Patch Large in a new double size value pack that includes nine large patches.  The product launch is being supported by a national broadcast advertising campaign which begins this week. “There is only one over-the-counter topical pain reliever that is FDA-approved like prescription medicine, and

Salonpas rolls out lidocaine gel patch

Salonpas rolls out lidocaine gel patch

FLORHAM PARK, N.J. — Hisamitsu America has expanded its Salonpas topical pain relief line with the new Salonpas Lidocaine 4% Pain Relieving Gel-Patch. Hisamitsu said Monday that the patch, which provides temporary relief of minor aches and pains, features the maximum strength of lidocaine available without a prescription. The product uses a proprietary hydro-gel technology to